|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N2800/52 | (2013.01) |
| G01N 33/574 | (2006.01) | ||
| G01N 33/68 | (2006.01) | ||
| G01N 33/57438 | (2013.01) | ||
| G01N 33/74 | (2006.01) | ||
| G01N 33/6863 | (2013.01) | ||
| G01N 33/74 | (2013.01) | ||
| G01N 33/6869 | (2013.01) | ||
| G01N2333/70525 | (2013.01) | ||
| G01N2333/53 | (2013.01) | ||
| G01N2333/54 | (2013.01) | ||
| G01N2333/7155 | (2013.01) | ||
| G01N2333/50 | (2013.01) | ||
| G01N2333/475 | (2013.01) | ||
| G01N2333/4753 | (2013.01) | ||
| G01N2333/515 | (2013.01) | ||
| G01N2333/8146 | (2013.01) |
| (11) | Number of the document | 3861347 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19790312.3 |
| Date of filing the European patent application | 2019-10-02 | |
| (97) | Date of publication of the European application | 2021-08-11 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2019/039012 |
| Date | 2019-10-02 |
| (87) | Number | WO 2020/071457 |
| Date | 2020-04-09 |
| (30) | Number | Date | Country code |
| 201862741861 P | 2018-10-05 | US |
| (72) |
FUNAHASHI Yasuhiro , JP
MINOSHIMA Yukinori , JP
KANEKIYO Michio , US
MATSUKI Masahiro , JP
ADACHI Yusuke , JP
KODAMA Kotaro , JP
|
| (73) |
Eisai R&D Management Co., Ltd. ,
4-6-10 Koishikawa
Bunkyo-ku, Tokyo 112-8088,
JP
|
| (54) | BIOMARKERS FOR A COMBINATION THERAPY COMPRISING LENVATINIB AND EVEROLIMUS |
| BIOMARKERS FOR A COMBINATION THERAPY COMPRISING LENVATINIB AND EVEROLIMUS |